Biocon is trading at RS. 334.45, up by 0.50 points or 0.15% from its previous close of RS. 333.95 on the BSE.

The stock opened at RS. 335.75 and hit an intraday high of RS. 339.45 and a low of RS. 333.30. A total of 38,090 shares have been exchanged so far.

Classified under BSE group 'A', Biocon has a face value of RS. 5. It touched a 52-week high of RS. 404.60 on January 21, 2025, and a 52-week low of RS. 270.00 on June 4, 2024. Over the past week, the stock's high and low stood at RS. 339.45 and RS. 327.95, respectively. The company's current market capitalization is RS. 40676.33 crore.

The promoter shareholding in Biocon stands at 60.64%, while institutional and non-institutional investors hold 21.38% and 17.97%, respectively.

In a key financial move, Biocon has raised RS. 600 crore through Commercial Papers (CPs) via private placement. The maturity date for these CPs is set for September 30, 2025.

Biocon is India’s largest and Asia’s leading biotechnology firm, with a strong focus on biopharmaceuticals and research services.